(ROP) Roper Technologies - Ratings and Ratios
Software, Technology, Medical Devices, Payment Processing, Financial Management
ROP EPS (Earnings per Share)
ROP Revenue
Description: ROP Roper Technologies
Roper Technologies, Inc. (NASDAQ:ROP) is a diversified technology company operating across multiple segments, including Application Software, Network Software, and Technology Enabled Products. The companys diverse portfolio includes software solutions for various industries such as education, insurance, healthcare, and financial services, as well as technology-enabled products for medical and industrial applications.
From a strategic perspective, ROPs business model is characterized by a strong focus on software and technology-enabled products, which provides a solid foundation for long-term growth. The companys diversified revenue streams across multiple industries and geographies reduce its dependence on any single market or segment. Key performance indicators (KPIs) to watch include revenue growth, operating margin expansion, and return on equity (ROE). ROPs ROE of 8.02% is a respectable figure, indicating a reasonable return on shareholder equity.
To further evaluate ROPs performance, we can examine additional KPIs such as the companys debt-to-equity ratio, interest coverage ratio, and cash flow generation. A strong balance sheet with manageable debt levels and robust cash flow generation would be indicative of a well-managed company. Furthermore, ROPs ability to generate consistent revenue growth through a combination of organic initiatives and strategic acquisitions will be crucial in driving long-term value creation for shareholders.
From a valuation perspective, ROPs price-to-earnings (P/E) ratio of 40.65 and forward P/E of 28.49 suggest that the companys shares may be fairly valued relative to its earnings growth prospects. However, a more detailed analysis of the companys earnings growth trajectory, industry trends, and competitive positioning would be necessary to determine whether the current valuation is justified.
ROP Stock Overview
| Market Cap in USD | 58,339m |
| Sub-Industry | Industrial Conglomerates |
| IPO / Inception | 1992-02-12 |
ROP Stock Ratings
| Growth Rating | 36.7 |
| Fundamental | 63.4% |
| Dividend Rating | 59.5 |
| Rel. Strength | -20.6 |
| Analysts | 4.11 of 5 |
| Fair Price Momentum | 463.24 USD |
| Fair Price DCF | 538.00 USD |
ROP Dividends
| Dividend Yield 12m | 0.75% |
| Yield on Cost 5y | 0.94% |
| Annual Growth 5y | 7.91% |
| Payout Consistency | 97.0% |
| Payout Ratio | 16.9% |
ROP Growth Ratios
| Growth Correlation 3m | -85.6% |
| Growth Correlation 12m | 32.6% |
| Growth Correlation 5y | 82.1% |
| CAGR 5y | 4.14% |
| CAGR/Max DD 5y | 0.15 |
| Sharpe Ratio 12m | 0.86 |
| Alpha | -14.25 |
| Beta | 0.633 |
| Volatility | 20.07% |
| Current Volume | 890k |
| Average Volume 20d | 642.4k |
| Stop Loss | 509.2 (-3%) |
| Signal | 0.50 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (1.54b TTM) > 0 and > 6% of Revenue (6% = 448.1m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 0.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -25.58% (prev -20.04%; Δ -5.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 2.41b > Net Income 1.54b (YES >=105%, WARN >=100%) |
| Net Debt (8.62b) to EBITDA (1.79b) ratio: 4.82 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.46 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (108.3m) change vs 12m ago 0.37% (target <= -2.0% for YES) |
| Gross Margin 68.87% (prev 69.90%; Δ -1.04pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 23.68% (prev 22.03%; Δ 1.66pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.63 (EBITDA TTM 1.79b / Interest Expense TTM 280.5m) >= 6 (WARN >= 3) |
Altman Z'' 2.86
| (A) -0.06 = (Total Current Assets 1.65b - Total Current Liabilities 3.56b) / Total Assets 33.22b |
| (B) 0.50 = Retained Earnings (Balance) 16.57b / Total Assets 33.22b |
| (C) 0.05 = EBIT TTM 1.58b / Avg Total Assets 31.53b |
| (D) 1.21 = Book Value of Equity 16.46b / Total Liabilities 13.59b |
| Total Rating: 2.86 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.36
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 3.47% = 1.73 |
| 3. FCF Margin 31.08% = 7.50 |
| 4. Debt/Equity 0.45 = 2.40 |
| 5. Debt/Ebitda 4.96 = -2.50 |
| 6. ROIC - WACC -2.76% = -3.45 |
| 7. RoE 8.08% = 0.67 |
| 8. Rev. Trend 99.59% = 4.98 |
| 9. Rev. CAGR 12.91% = 1.61 |
| 10. EPS Trend 58.18% = 1.45 |
| 11. EPS CAGR 4.49% = 0.45 |
What is the price of ROP shares?
Over the past week, the price has changed by -2.19%, over one month by -4.26%, over three months by -7.11% and over the past year by +0.01%.
Is Roper Technologies a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ROP is around 463.24 USD . This means that ROP is currently overvalued and has a potential downside of -11.76%.
Is ROP a buy, sell or hold?
- Strong Buy: 10
- Buy: 2
- Hold: 6
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the ROP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 635.8 | 21.1% |
| Analysts Target Price | 632 | 20.4% |
| ValueRay Target Price | 511.1 | -2.6% |
Last update: 2025-08-05 03:04
ROP Fundamental Data Overview
CCE Cash And Equivalents = 242.4m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 38.0161
P/E Forward = 29.4985
P/S = 7.8045
P/B = 2.9686
P/EG = 2.8952
Beta = 1.02
Revenue TTM = 7.47b USD
EBIT TTM = 1.58b USD
EBITDA TTM = 1.79b USD
Long Term Debt = 7.86b USD (from longTermDebt, last quarter)
Short Term Debt = 999.8m USD (from shortTermDebt, last quarter)
Debt = 8.86b USD (Calculated: Short Term 999.8m + Long Term 7.86b)
Net Debt = 8.62b USD (from netDebt column, last quarter)
Enterprise Value = 66.96b USD (58.34b + Debt 8.86b - CCE 242.4m)
Interest Coverage Ratio = 5.63 (Ebit TTM 1.58b / Interest Expense TTM 280.5m)
FCF Yield = 3.47% (FCF TTM 2.32b / Enterprise Value 66.96b)
FCF Margin = 31.08% (FCF TTM 2.32b / Revenue TTM 7.47b)
Net Margin = 20.62% (Net Income TTM 1.54b / Revenue TTM 7.47b)
Gross Margin = 68.87% ((Revenue TTM 7.47b - Cost of Revenue TTM 2.33b) / Revenue TTM)
Tobins Q-Ratio = 4.07 (Enterprise Value 66.96b / Book Value Of Equity 16.46b)
Interest Expense / Debt = 0.89% (Interest Expense 79.1m / Debt 8.86b)
Taxrate = 21.24% (from yearly Income Tax Expense: 417.9m / 1.97b)
NOPAT = 1.24b (EBIT 1.58b * (1 - 21.24%))
Current Ratio = 0.46 (Total Current Assets 1.65b / Total Current Liabilities 3.56b)
Debt / Equity = 0.45 (Debt 8.86b / last Quarter total Stockholder Equity 19.63b)
Debt / EBITDA = 4.96 (Net Debt 8.62b / EBITDA 1.79b)
Debt / FCF = 3.82 (Debt 8.86b / FCF TTM 2.32b)
Total Stockholder Equity = 19.06b (last 4 quarters mean)
RoA = 4.63% (Net Income 1.54b, Total Assets 33.22b )
RoE = 8.08% (Net Income TTM 1.54b / Total Stockholder Equity 19.06b)
RoCE = 5.87% (Ebit 1.58b / (Equity 19.06b + L.T.Debt 7.86b))
RoIC = 4.59% (NOPAT 1.24b / Invested Capital 27.14b)
WACC = 7.34% (E(58.34b)/V(67.20b) * Re(8.35%)) + (D(8.86b)/V(67.20b) * Rd(0.89%) * (1-Tc(0.21)))
Shares Correlation 5-Years: 100.0 | Cagr: 0.30%
Discount Rate = 8.35% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 79.13% ; FCFE base≈2.22b ; Y1≈2.55b ; Y5≈3.55b
Fair Price DCF = 538.0 (DCF Value 57.84b / Shares Outstanding 107.5m; 5y FCF grow 17.15% → 3.0% )
Revenue Correlation: 99.59 | Revenue CAGR: 12.91%
Revenue Growth Correlation: -26.65%
EPS Correlation: 58.18 | EPS CAGR: 4.49%
EPS Growth Correlation: -43.32%
Additional Sources for ROP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle